News

At the forefront of medical technology, the European ThrombUS+ programme is pioneering innovation with a portable ultrasound device for early detection and continuous monitoring of deep vein thrombosis (DVT). This serious condition, which can be asymptomatic in up to two-thirds of cases, requires innovative solutions for effective prevention and diagnosis.

 

ThrombUS+ is funded with €9.5 million from the Horizon Europe Innovation Action, led by Professor Eleni Kaldoudi from the Institute for Language and Speech Processing at the Athena Research Center. Professor Kaldoudi leads an international consortium of research institutions and companies from Greece, Germany, France, Germany, France, Lithuania, Italy, Finland, Finland, Germany, Italy, Spain and the USA.

 

ThrombUS+ is developing an innovative wearable device that combines ultrasound with artificial intelligence, enabling automatic, continuous imaging of the lower limbs without the need for human intervention. This innovation is set to transform diagnostic practices and significantly support healthcare professionals.

 

Professor Kaldoudi observes: "Developing a wearable device for the diagnosis and prevention of DVT has many challenges. ThrombUS+ addresses these challenges by combining technological and regulatory innovation, with the international collaboration and experience of the partners playing a critical role in the success of the project."

 

Over its 42-month duration, ending in 2027, the project will utilize data from three large-scale clinical trials to train AI models and undergo clinical validation and multicenter testing.